Tianjin Chase Sun Pharmaceutical Co Ltd (300026) — Capital Reinvestment Ratio
Tianjin Chase Sun Pharmaceutical Co Ltd (300026) has a Capital Reinvestment Ratio of 0.14x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥153.30 Million) in capital expenditures (CN¥21.58 Million). Check Tianjin Chase Sun Pharmaceutical Co Ltd tangible book value ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Tianjin Chase Sun Pharmaceutical Co Ltd Capital Reinvestment Ratio (2006–2024)
This chart tracks Tianjin Chase Sun Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 19 annual periods. For the full cash flow conversion analysis, see 300026 cash generation efficiency.
Annual Capital Reinvestment Ratio for Tianjin Chase Sun Pharmaceutical Co Ltd (2006–2024)
Year-by-year Capital Reinvestment Ratio for Tianjin Chase Sun Pharmaceutical Co Ltd from 2006 to 2024. See how much free cash does Tianjin Chase Sun Pharmaceutical Co Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.23x | CN¥852.24 Million | CN¥193.12 Million | ▼ -0.1% |
| 2023 | 0.23x | CN¥1.53 Billion | CN¥347.12 Million | ▼ -78.0% |
| 2022 | 1.03x | CN¥745.35 Million | CN¥770.27 Million | ▼ -40.3% |
| 2021 | 1.73x | CN¥391.60 Million | CN¥677.45 Million | ▼ -39.7% |
| 2020 | 2.87x | CN¥196.66 Million | CN¥563.78 Million | ▲ +4.8% |
| 2019 | 2.73x | CN¥216.10 Million | CN¥591.01 Million | ▲ +260.0% |
| 2018 | 0.76x | CN¥388.19 Million | CN¥294.89 Million | ▲ +47.1% |
| 2017 | 0.52x | CN¥742.38 Million | CN¥383.34 Million | ▼ -44.3% |
| 2016 | 0.93x | CN¥448.08 Million | CN¥415.52 Million | ▼ -49.8% |
| 2015 | 1.85x | CN¥121.00 Million | CN¥223.35 Million | ▲ +55.2% |
| 2014 | 1.19x | CN¥149.94 Million | CN¥178.37 Million | ▲ +59.4% |
| 2013 | 0.75x | CN¥143.60 Million | CN¥107.20 Million | ▼ -48.6% |
| 2012 | 1.45x | CN¥152.21 Million | CN¥221.17 Million | ▼ -80.3% |
| 2011 | 7.37x | CN¥35.64 Million | CN¥262.51 Million | ▲ +201.7% |
| 2010 | 2.44x | CN¥46.25 Million | CN¥112.90 Million | ▲ +561.8% |
| 2009 | 0.37x | CN¥135.06 Million | CN¥49.82 Million | ▼ -40.6% |
| 2008 | 0.62x | CN¥77.74 Million | CN¥48.28 Million | ▲ +661.3% |
| 2007 | 0.08x | CN¥72.01 Million | CN¥5.87 Million | ▼ -96.8% |
| 2006 | 2.54x | CN¥1.22 Million | CN¥3.12 Million | — |